CMMI Open to Feedback, but EOM Out of the Blue

The Center for Medicare and Medicaid Innovation (CMMI) was a strong collaborator during the Oncology Care Mode (OCM), but the timing of the Enhancing Oncology Model came as a surprise.

EP: 1.No Successor to OCM Would Disappoint

Now Viewing

EP: 2.CMMI Open to Feedback, but EOM Out of the Blue

EP: 3.Some Practices That Did Not Do OCM Are Applying

EP: 4.Seven Tumor Types: Pros and Cons

EP: 5.A Model That Is Built to “Win”

EP: 6.Addressing Health Equity and Social Needs

EP: 7.Is Five Years Long Enough?

EP: 8.Changes to MEOS and Barriers to Entry

EP: 9.Small Practices and Dual Risk: Considerations and Approaches

EP: 10.Does Pooling Make Sense?

EP: 11.What Would You Change About the EOM?

Kashyap Patel, MD, CEO, Carolina Blood and Cancer Care Associates and president, Community Oncology Alliance, makes a point about practices that were successful under the OCM. Led by moderator Stuart Staggs, MSIE, senior director, strategic programs, The US Oncology Network, panelists Patel and Stephen Schleicher, MD, MBA, chief medical officer, Tennessee Oncology, note that community oncologists are pleased to see CMMI present the Enhancing Oncology Model (EOM), amid the setback of the COVID-19 pandemic. Schleicher said that practices await word on details of the EOM and look forward to collaborating as they did under the OCM.